6Yano S,Herbst RS,Shmohala H,et al.Treatment for malignant pleural effusions of human lung adocarcinoma by inhibition of vascular endothelial growth lung Aden carcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation [ J ].Clin Cancer Res,2000,6 (3):957-959.
8Abu-Ghazaleh R Kabir J,Jia H,et al.Src mediates stimualtion by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861 and migration and anti-apoptosis in endothelial cells [J].Biochem J,2001,360(Pt1):255-264.
9Bates DO,Heald RI,Carry FE,et al.VEGF increases rana vascular permeability and compliance by different signaling pathways [J].J Physiol,2001,P53(ptl):263-265.
4J. E. Gershenwald, I. J. Fidler Targeting lymphatic metastasis. Science, 2002,296 : 1811--1812.
5M. Meyer,M. Clauss,A. L. Wienhues et al. A novel vascular endothelial growth factor encoded by Orf virus,VEGF-E,mediates angiogenesis via signalliing through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tryosine kinases. EMBOJ, 1999,18 : 363--374.
6S. J. Mandriota, L. Jussila, M. Jeltsch, A. Compagni et al. Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metatasis. EMBO ,2001,20(4) :672--682.
7K. Iljin,M. J. Karkkainen,E. C. Lawrence et al VEGFR3 gene st ructure, regulatory region ,and sequence polymorphisms. FASEB, 2001,15: 1028--1036.
9P. Salven, A. Lymboussaki, P. Heikkila et al. Vascular endothelial growth factors VEGF-B and VEGF-C areexpressed in human tumors. American Jourmal of Pathology. 1998,153 (1) : 103--108.
10T. Veikkola, L. Jussila, T. Makinen et al. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO,2001,20:1223--1231.
